BioMarin Pharmaceutical Statistics

Total Valuation

BIT:1BMRN has a market cap or net worth of EUR 8.80 billion. The enterprise value is 8.01 billion.

Market Cap	8.80B
Enterprise Value	8.01B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	193.27M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	98.03%
Float	191.21M

Valuation Ratios

The trailing PE ratio is 29.60 and the forward PE ratio is 9.69.

PE Ratio	29.60
Forward PE	9.69
PS Ratio	3.21
PB Ratio	1.70
P/TBV Ratio	1.85
P/FCF Ratio	14.25
P/OCF Ratio	12.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.78, with an EV/FCF ratio of 12.98.

EV / Earnings	26.97
EV / Sales	2.91
EV / EBITDA	12.78
EV / EBIT	14.42
EV / FCF	12.98

Financial Position

The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.11.

Current Ratio	5.21
Quick Ratio	3.25
Debt / Equity	0.11
Debt / EBITDA	0.88
Debt / FCF	0.89
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 5.94% and return on invested capital (ROIC) is 9.09%.

Return on Equity (ROE)	5.94%
Return on Assets (ROA)	5.58%
Return on Invested Capital (ROIC)	9.09%
Return on Capital Employed (ROCE)	9.52%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	851,767
Profits Per Employee	92,257
Employee Count	3,221
Asset Turnover	0.44
Inventory Turnover	1.20

Taxes

In the past 12 months, BIT:1BMRN has paid 113.77 million in taxes.

Income Tax	113.77M
Effective Tax Rate	27.69%

Stock Price Statistics

The stock price has decreased by -16.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.97%
50-Day Moving Average	49.35
200-Day Moving Average	48.36
Relative Strength Index (RSI)	40.69
Average Volume (20 Days)	28

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.05

Income Statement

In the last 12 months, BIT:1BMRN had revenue of EUR 2.74 billion and earned 297.16 million in profits. Earnings per share was 1.54.

Revenue	2.74B
Gross Profit	1.45B
Operating Income	554.23M
Pretax Income	410.93M
Net Income	297.16M
EBITDA	615.68M
EBIT	554.23M
Earnings Per Share (EPS)	1.54

Balance Sheet

The company has 1.33 billion in cash and 547.53 million in debt, giving a net cash position of 781.64 million.

Cash & Cash Equivalents	1.33B
Total Debt	547.53M
Net Cash	781.64M
Net Cash Per Share	n/a
Equity (Book Value)	5.18B
Book Value Per Share	26.96
Working Capital	2.72B

Cash Flow

In the last 12 months, operating cash flow was 705.20 million and capital expenditures -87.76 million, giving a free cash flow of 617.45 million.

Operating Cash Flow	705.20M
Capital Expenditures	-87.76M
Depreciation & Amortization	61.58M
Net Borrowing	n/a
Free Cash Flow	617.45M
FCF Per Share	n/a

Margins

Gross margin is 52.81%, with operating and profit margins of 20.20% and 10.83%.

Gross Margin	52.81%
Operating Margin	20.20%
Pretax Margin	14.98%
Profit Margin	10.83%
EBITDA Margin	22.44%
EBIT Margin	20.20%
FCF Margin	22.51%

Dividends & Yields

BIT:1BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	3.38%
FCF Yield	7.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BMRN has an Altman Z-Score of 5.77 and a Piotroski F-Score of 5.

Altman Z-Score	5.77
Piotroski F-Score	5